Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

Teen with Down Syndrome Named Miss Congeniality at Miss Teen USA

Kayla Kosmalski, 18, has made history and captured hearts as the first contestant with Down syndrome to compete in Miss Teen USA. Her participation not only broke barriers but also earned her the title of Miss Congeniality, celebrating her spirit and positive impact throughout the competition. Additionally, Kayla serves as the 2024 Ambassador for Hearts of Joy International, an organization dedicated to providing life-saving heart surgeries for babies with Down syndrome. Her groundbreaking involvement in the pageant and her advocacy work highlight significant strides towards inclusivity and representation in high-profile events.

PrevPrevious1945 Message in a Bottle Unearthed by Hurricane Debby
NextCommunity Rallies for Veteran: Over $365K Raised to Support Disabled Vet and WifeNext

Recent Articles

Happy News

Scientists Just Proved That Your Brain Can Dream While You Are Wide Awake

May 11, 2026

A study from the Paris Brain Institute, published in Cell Reports, has overturned something most people take for granted: that dreaming and waking are two cleanly separate mental states, each with their own type of thoughts. Researchers monitored 92 adults using EEG caps as they drifted into and out of

Read More
Happy News

A Kitten Found Covered Head To Tail In Industrial Glue Just Made A Full Recovery And Has A New Home

May 11, 2026

When a good Samaritan in Fort Worth, Texas, discovered a small kitten stuck in a bucket of industrial-strength glue near an industrial area in April and rushed him to the Humane Society of North Texas, shelter staff were not sure the tiny animal would survive the night. The glue was

Read More
Happy News

The FDA Just Gave Pancreatic Cancer Patients Early Access To A Pill That Doubled Survival Time

May 11, 2026

The Food and Drug Administration has authorized early expanded access to a new pill called daraxonrasib, developed by Revolution Medicines, giving patients with advanced pancreatic cancer a chance to receive the experimental treatment while it awaits full regulatory approval, in a move the agency completed just two days after receiving

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2026 HappyNews.